For Quick Alerts
For Daily Alerts

Suven Life Shares Surge 5% On Getting Patent For Drug

By Super

Mumbai, Mar 14 (PTI) Shares of Suven Life Sciences surged 5 per cent today as the company has been granted a patent each by China, Eurasia and Hong Kong for a drug used in the treatment of neuro-degenerative diseases.

The stock soared 5 per cent to Rs 211 on BSE. On NSE, shares of the company climbed 4.74 per cent to Rs 210.90.

Suven Life Shares Surge 5% On Getting Patent For Drug
Suven Life Sciences: Quotes, News
BSE 272.20BSE Quote0.5 (-0.18%)
NSE 271.95NSE Quote1.05 (-0.39%)

The company has been granted "one product patent from China, one product patent from Eurasia and one product patent from Hong Kong corresponding to the New Chemical Entities (NCEs) for the treatment of disorders associated with neuro-degenerative diseases", it said in a BSE filing.

The patents will be valid till 2032. "We are very pleased by the grant of these patents to Suven for our pipeline of molecules in the CNS (central nervous system) arena, which are being developed for cognitive disorders with high unmet medical need with a huge market potential globally," said Venkat Jasti, CEO Suven Life.


Read more about: suven life
Company Search
Enter the first few characters of the company's name or the NSE symbol or BSE code and click 'Go'


We use cookies to ensure that we give you the best experience on our website. This includes cookies from third party social media websites and ad networks. Such third party cookies may track your use on Goodreturns sites for better rendering. Our partners use cookies to ensure we show you advertising that is relevant to you. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on Goodreturns website. However, you can change your cookie settings at any time. Learn more